Skip to content

Homoeopathic Treatment Of Patchy Hair Loss (Alopecia Areata)

An Open Label Prospective Interventional Pragmatic Study to assess the effectiveness of Individualized Homoeopathic Medicine in Alopecia Areata - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067792
Enrollment
30
Registered
2024-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L639- Alopecia areata, unspecified

Interventions

Intervention1: Administration of individualized homoeopathic medicines: Individualized homoeopathic medicine will be prescribed after a detailed case history and repertorization. Potency of medicine w
dosage and repetition depending upon the individual requirement of the cases. The medicines have been procured from a Good Manufacturing Practice (GMP)-certified firm. Duration of intervention is six

Sponsors

Dr Asmita Dutta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Patients fulfilling the diagnostic criteria of alopecia areata. -Patients using internal medication and topical agents from conventional medicines for alopecia areata will be included after a washout period of 15 days. -Patients who give consent for study and administration of homoeopathic medicine.

Exclusion criteria

Exclusion criteria: -Patients with uncontrolled systemic and neurological illness. -Patients who are terminally ill, under immunosuppressive treatment or self-reported immunocompromised state. -Diagnosed case of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure. -Pregnant and lactating women. -Unwilling to take part and not giving consent to join the study. -Substance abuse and or dependence.

Design outcomes

Primary

MeasureTime frame
Severity of Alopecia Areata Tool (SALT) SCORETimepoint: Every 21 days

Secondary

MeasureTime frame
Measure Your Medical Outcome (MYMOP) QuestionnaireTimepoint: One at baseline and other at the end of study

Countries

India

Contacts

Public ContactDr Asmita Dutta

Nehru Homoeopathic Medical College and Hospital

drbipin.jethani@gmail.com9810146343

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026